Meta-analysis of interventions for medication adherence to antihypertensives

Annals of Pharmacotherapy

Volumn 38, Issue 10, 2004, Pages 1617-1624

  Takiya, Liza N ^a   Peterson, Andrew M ^a   Finley, Rebecca S ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Adherence; Antihypertensive; Compliance; Hypertension; Medication

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR MODIFICATION; CAREGIVER; CLINICAL TRIAL; EMBASE; FEMALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MALE; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCINFO; PUBLICATION; SYSTEMATIC REVIEW; TREATMENT PLANNING;

ANTIHYPERTENSIVE AGENTS; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION;

EID: 4644341648     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D268     Document Type: Article

References (36)

1. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
2. Trilling JS, Froom J. The urgent need to improve hypertension care. Arch Fam Med 2000;9:794-801.
3. Morris LS, Schulz RM. Patient compliance-an overview. J Clin Pharm Ther 1992;17:283-95.
4. Feldman R, Bacher M, Campbell N. Adherence to pharmacologic management of hypertension. Can J Public Health 1998;89(suppl 1):16-8.
5. Levy RA. Improving compliance with prescription medications: an important strategy for containing health-care costs. Medical Interface 1989; (March):34-7.
6. Iskedjian M, Einarson TR, MacKeigan LD, Shear N, Addis A, Mittmann N, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 2002;24:302-16.
7. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
8. Gorelick PB, Sacco RL, Smith DB. Prevention of a first stroke. JAMA 1999;281:1112-20.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program. JAMA 1991;265:3255-64.
10. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, et al. Improvement of medication compliance in controlled hypertension. Lancet 1976;1:1265-8.
11. Homedes N, Ugalde N. Improving the use of pharmaceuticals through patient and community level interventions. Soc Sci Med 2001;52:99-134.
12. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-61.
13. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996;348:383-6.
14. Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV, eds. The handbook of research synthesis. New York: Russell Sage Foundation, 1994:231-44.
15. Baird MG, Bentley-Taylor MM, Carruthers SG, Dawson KG, Laplante LE, Larochelle R, et al. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med 1984;7:95-102.
16. Becker LA, Glanz K, Sobel E, Mossey J, Zinn SL, Knott KA. A randomized trial of special packaging of antihypertensive medications. J Fam Pract 1986;22:357-61.
17. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
18. Eshelman FN, Fitzloff J. Effect of packaging on patient compliance with an antihypertensive medication. Curr Ther Res Clin Exp 1976;20:215-9.
19. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, et al. A telecommunications system for monitoring and counseling patients with hypertension: impact on medication adherence and blood pressure control. Am J Hypertens 1996;9:285-92.
20. Gabriel M, Gagnon JP, Bryan CK. Improved patients compliance through use of a daily drug reminder chart. Am J Public Health 1977;67:968-9.
21. Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens 1999;17:1627-31.
22. Leenen FHH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol 1997;13:914-20.
23. McKenney JM, Munroe WP, Wright JT. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32:277-83.
24. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973;48:1104-11.
25. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;11:1384-9.
26. Nessman DG, Camahan JE, Nugent CA. Increasing compliance: patient-operated hypertension groups. Arch Intern Med 1980;140:1427-30.
27. Rehder TL, McCoy LK, Blackwell B, Whitehead W, Robinson A. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm 1980;37:379-85.
28. Saunders LD, Irwig LM, Gear JS, Ramushu DL. A randomized controlled trial of compliance improving strategies in Soweto hypertensives. Med Care 1991;29:669-78.
29. Sclar DA, Chin A, Skaer TL, Okamoto MP, Nakahiro RK, Gill MA. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther 1991;13:489-95.
30. Paramore LC, Halpern MT, Lapuerta P. Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Manag Care 2001;7:389-98.
31. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998;20:1-11.
32. Benson S, Vance-Bryan K, Raddatz J. Time to patient discontinuation of antihypertensive drugs in different classes. Am J Health Syst Pharm 2000;57:51-4.
33. Luscher TF, Vetter H, Siegenthaler W, Vetter W. Compliance in hypertension: facts and concepts. J Hypertens 1985;3(suppl 1):3-10.
34. American Heart Association, www.americanheart.org (accessed 2003 Mar 20).
35. Nichol MB, Venturini F, Sung JCY. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999;33:531-40. DOI 10.1345/aph.18233
36. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999;282:1054-60.